A R T I C L E S
Mart´ın et al.
NBF4IrP: C, 33.84; H, 5.30; N, 2.63. Found: C, 33.44; H, 5.30; N,
2.63. MS (FAB+, m/z (%)): 405 (96) [M+-NCMe]. 1H NMR (CDCl3,
293 K): δ 0.77 (m, 1H, IrCH), 0.89, 1.16 (both m, 1H each, CH2),
1.54 (m, 4H, CH2), 1.83 (d, JHP ) 10.1, 9H, PCH3), 2.07 (m, 2H, CH2),
2.19 (br, 3H, NCCH3), 2.83, 3.59 (both m, 2H each, η2-CH2dCH2),
4.72, 5.69, 6.31 (all m, 1H each, CH). 31P{1H} NMR (CDCl3, 293 K):
δ -41.33 (s). 13C{1H} NMR (CDCl3, 293 K): δ 2.82 (s, NCCH3),
15.75 (d, JCP ) 38.1, PCH3), 21.84 (br, IrCH), 23.44 (d, JCP ) 2.2,
CH2), 25.06 (s, CH2), 48.45 (s, η2-CH2dCH2), 48.84 (d, JCP ) 7.6,
CH2), 50.16 (d, JCP ) 6.3, CH2), 77.33 (s, CH), 88.08 (d, JCP ) 19.6,
CH), 98.36 (s, CH), 117.89 (br, NCCH3).
(s, CH), 72.17, (d, JCP ) 10.2, CH), 73.83 (d, JCP ) 8.2, CH), 83.24
(s, η2-CH2dCHOC(O)CH3), 118.50 (s, NCCH3), 171.07 (s, η2-CH2d
CHOC(O)CH3).
Preparation of [Ir(1,2,5,6-η-C8H12){K-O-η2-OC(Me)OC2H3}-
(PMe3)]BF4 (6). A solution of 1 (200 mg, 0.41 mmol) in CH2Cl2 (8
mL) was reacted with vinyl acetate (2.3 mL, 24.6 mmol) and rapidly
concentrated to ca. 0.5 mL under reduced pressure. The addition of
diethyl ether produced the precipitation of a pale yellow solid, which
was separated by decantation, washed with diethyl ether, and dried in
vacuo: yield 180.9 mg (83%). Anal. Calcd for C15H27BF4IrO2P: C,
32.80; H, 4.95. Found: C, 32.38; H, 4.82. MS (FAB+, m/z (%)) 463
1
(57) [M+]. IR (cm-1): 1760, 1647, 1596 ν(CO). H NMR (CD2Cl2,
Preparation of [Ir(1-K-4,5,6-η-C8H12)(NCMe)(η2-C3H6)(PMe3)]-
BF4 (4). The compound was prepared through any of the two methods
described for 3 by using propylene instead of ethylene. Method B gave
4 as a pale yellow solid in 73% yield. Anal. Calcd for C16H30NBF4IrP:
C, 35.17; H, 5.53; N, 2.56. Found: C, 34.78; H, 5.23; N, 2.35. MS
253 K): δ 1.58 (m, 1H, CH2), 1.61 (m, 1H, κ-O-η2-CH2dCHOC(O)-
CH3), 1.76 (d, JHP ) 10.1, 9H, PCH3), 1.82 (m, 1H, κ-O-η2-CH2d
CHOC(O)CH3), 1.86, 2.09 (both m, 1H each, CH2), 2.24 (s, 3H, κ-O-
η2-CH2dCHOC(O)CH3), 2.32, 2.37, 2.40 (all m, 1H each, CH2), 2.43
(m, 1H, CH), 2.59, 2.96 (both m, 1H each, CH2), 3.02, 3.65, 3.82 (all
m, 1H each, CH), 7.26 (m, 1H, κ-O-η2-CH2dCHOC(O)CH3). 31P{1H}
NMR (CD2Cl2, 253 K): δ -39.63 (s). 13C{1H} NMR (CD2Cl2, 253
K): δ 15.01 (d, JCP ) 31.8, PCH3), 18.42 (s, κ-O-η2-CH2dCHOC-
(O)CH3), 19.79 (d, JCP ) 6.4, κ-O-η2-CH2dCHOC(O)CH3), 26.02 (d,
JCP ) 4.1, CH2), 31.57, 33.87 (both s, CH2), 35.79 (d, JCP ) 2.4, CH2),
62.38 (d, JCP ) 3.2, CH), 68.37 (d, JCP ) 6.0, CH), 73.63 (s, CH),
75.76 (d, JCP ) 9.1, CH), 90.91 (d, JCP ) 22.9, κ-O-η2-CH2dCHOC-
(O)CH3), 187.74 (d, JCP ) 10.2, κ-O-η2-CH2dCHOC(O)CH3).
Preparation of [Ir(1,2,5,6-η-C8H12){K-O-η2-OC(Me)OC2H3}-
(PMe3)]BPh4 (6-BPh4). The compound was prepared as described for
6 but starting from [Ir(1,2,5,6-η-C8H12)(NCMe)(PMe3)]BPh4 (200 mg,
0.27 mmol) and vinyl acetate (1.50 mL, 16.29 mmol): yield 186.8 mg
(88%). Anal. Calcd for C39H47BIrO2P: C, 59.92; H, 6.06. Found: C,
59.47; H, 5.69. The crystals used in the X-ray diffraction experiment
were obtained by slow diffusion of hexane into a saturated solution of
6-BPh4 in CH2Cl2 at 253 K.
1
(FAB+, m/z (%)): 459 (12) [M+], 418 (16) [M+-NCMe]. H NMR
(CD2Cl2, 233 K): δ 0.69 (m, 1H, IrCH), 0.87, 1.14, 1.51, 1.56, 1.58
(all m, 1H each, CH2), 1.68 (d, JHH ) 3.3, 3H, η2-CH2dCHCH3), 1.72
(m, 1H, CH2), 1.77 (d, JHP ) 9.9, 9H, PCH3), 2.07, 2.12 (both m, 1H
each, CH2), 2.16 (s, 3H, NCCH3), 2.85 (dd, JHH ) 9.0, 7.8, 1H, η2-
CH2dCHCH3), 3.02 (dd, JHH ) 11.7, 7.8, 1H, η2-CH2dCHCH3), 4.64
(m, 1H, CH), 4.98 (m, 1H, η2-CH2dCHCH3), 5.32, 5.75 (both m, 1H
each, CH). 31P{1H} NMR (CD2Cl2, 233 K): δ -41.23 (s). 13C{1H}
NMR (CD2Cl2, 233 K): δ 3.28 (s, NCCH3), 15.44 (d, JCP ) 37.9,
PCH3), 21.17 (s, η2-CH2dCHCH3), 22.72 (d, JCP ) 4.0, IrCH), 24.14
(d, JCP ) 2.6, CH2), 25.02 (s, CH2), 48.47 (d, JCP ) 7.4, CH2), 50.01
(d, JCP ) 6.6, CH2), 53.44 (d, JCP ) 5.1, η2-CH2dCHCH3), 64.56 (s,
η2-CH2dCHCH3), 74.29 (s, CH), 94.33 (d, JCP ) 21.7, CH), 98.71 (s,
CH), 117.72 (s, NCCH3).
Reaction of 1 with Vinyl Acetate. A solution of 1 (60.82 mg, 0.12
mmol) in CD2Cl2 (0.45 mL) contained in an NMR tube was treated
with vinyl acetate (11 µL, 0.12 mmol) and introduced in the NMR
spectrometer at 293 K. The 31P{1H} NMR spectrum displayed a singlet
attributable to complex [Ir(1,2,5,6-η-C8H12){κ-O-η2-OC(Me)OC2H3}-
(PMe3)]BF4 (6) together with a broad signal at ca. δ -19. Upon
decreasing the temperature this latter signal was found to progressively
shift to higher field and simultaneously broaden. After decoalescence,
the signal gave rise in the 193 K NMR spectrum to two major
compounds in 2:1 molar ratio, identified as the isomers [Ir(1,2,5,6-η-
C8H12)(NCMe)(η2-C2H3OC(O)CH3}(PMe3)]BF4 (5). A more detailed
evolution of the 31P{1H} NMR spectrum with the temperature can be
found as Supporting Information. Data for the major isomer of 5 is as
Preparation of [Ir(1-K-4,5,6-η-C8H12){K-O-η2-OC(Me)OC2H3}-
(PMe3)]BF4 (7). A solution of 1 (100 mg, 0.20 mmol) in CH2Cl2 (8
mL) was treated with vinyl acetate (56 µL, 0.60 mmol) and allowed to
react at the reflux temperature for 8 h. The resulting solution was filtered
through Celite, concentrated to ca. 0.5 mL, and cooled at 233 K.
Addition of diethyl ether produced the precipitation of a pale yellow
solid, which was separated by decantation, washed with diethyl ether,
and dried in vacuo: yield 81.3 mg (74%). Anal. Calcd for C15H27BF4-
IrO2P: C, 32.79; H, 4.69. Found: C, 32.59; H, 4.69. MS (FAB+, m/z
(%)): 463 (100) [M+]. IR (cm-1): 1740, 1654, 1597 ν(CO). 1H NMR
(acetone-d6, 293 K): δ 0.88 (m, 2H, CH2), 1.33 (m, 2H, CH2 + CH),
1.49 (m, 1H, CH2), 1.69 (m, 2H, CH2), 1.95 (d, JHP ) 10.8, 9H, PCH3),
2.04 (s, 3H, κ-O-η2-CH2dCHOC(O)CH3), 2.20 (m, 2H, CH2), 2.92
(ddd, JHH ) 5.5, 4.2, JHP ) 4.6, 1H, κ-O-η2-CH2dCHOC(O)CH3), 3.28
(ddd, JHP ) 10.9, JHH ) 7.2, 4.2, 1H, κ-O-η2-CH2dCHOC(O)CH3),
4.58, 5.93, 6.67 (all m, 1H each, CH), 7.95 (ddd, JHH ) 7.2, 5.5, JHP
) 4.3, 1H, κ-O-η2-CH2dCHOC(O)CH3). 31P{1H} NMR (acetone-d6,
293 K): δ -34.41 (s). 13C{1H} NMR (acetone-d6, 293 K): δ 14.64
(d, JCP ) 39.0, PCH3), 18.61 (s, κ-O-η2-CH2dCHOC(O)CH3), 22.89
(d, JCP ) 2.7, CH2), 24.48 (s, CH2), 24.91 (d, JCP ) 3.6, CH), 37.36
(d, JCP ) 6.7, κ-O-η2-CH2dCHOC(O)CH3), 48.14 (d, JCP ) 6.4, CH2),
49.78 (d, JCP ) 7.2, CH2), 79.21 (s, CH), 85.58 (d, JCP ) 6.1, κ-O-
1
follows. H NMR (CD2Cl2, 193 K): δ 1.19 (m, 1H, η2-CH2dCHOC-
(O)CH3), 1.55 (m, 1H, CH2), 1.72 (d, JHP ) 9.6, 9H, PCH3), 1.82 (m,
1H, CH2), 2.09 (s, 3H, η2-CH2dCHOC(O)CH3), 2.14 (m, 1H, CH),
2.19 (m, 1H, CH2), 2.20 (m, 1H, η2-CH2dCHOC(O)CH3), 2.27, 2.51,
2.55, 2.62, 3.13 (all m, 1H each, CH2), 3.13, 3.45, 3.75 (all m, 1H
each, CH), 6.87 (m, 1H, η2-CH2dCHOC(O)CH3). 31P{1H} NMR
(CD2Cl2, 193 K): δ -47.94 (s). 13C{1H} NMR (CD2Cl2, 193 K): δ
4.08 (s, NCCH3), 15.16 (d, JCP ) 30.4, PCH3), 20.83 (d, JCP ) 6.7,
η2-CH2dCHOC(O)CH3), 21.37 (s, η2-CH2dCHOC(O)CH3), 27.24,
30.69, 36.00, 36.46 (all s, CH2), 63.85 (d, JCP ) 5.3, CH), 68.96 (d,
JCP ) 11.5, CH), 71.78 (s, CH), 75.36 (d, JCP ) 20.3, CH), 84.81 (s,
η2-CH2dCHOC(O)CH3), 117.25 (s, NCCH3), 169.94 (s, η2-CH2d
CHOC(O)CH3). Data for the minor isomer of 5 is as follows. 1H NMR
η2-CH2dCHOC(O)CH3), 94.40 (d, JCP ) 17.7, CH), 102.41 (d, JCP
)
0.8, CH), 183.24 (d, JCP ) 3.4, κ-O-η2-CH2dCHOC(O)CH3). The
crystals used in the X-ray determination were obtained by slow diffusion
of diethyl ether into a saturated solution of 7 in CH2Cl2 at 253 K.
Preparation of [IrCl(η2-C3H6)(PiPr3)2] (28). A suspension of [Ir(µ-
Cl)(coe)2]2 (679.4 mg, 0.75 mmol) in pentane (15 mL) was treated with
PiPr3 (637 µL, 3.34 mmol) at 273 K. After 10 min of reaction, the
resulting suspension was protected from the light, treated with propylene
at atmospheric pressure, and then cooled at 233 K. The resulting solution
was concentrated to ca. 0.5 mL to give an orange solid, which was
separated by decantation, washed with pentane at 233 K, and dried in
(CD2Cl2, 193 K): δ 1.36, 1.60 (both m, 1H each, CH2), 1.72 (d, JHP
)
9.6, 9H, PCH3), 1.85 (s, 3H, η2-CH2dCHOC(O)CH3), 2.22, 2.38, 2.62
(all m, 1H each, CH2), 2.67 (m, 1H, η2-CH2dCHOC(O)CH3), 2.90 (m,
1H, CH2), 2.99 (m, 1H, CH), 3.00, 3.13 (both m, 1H each, CH2), 3.33
(m, 1H, CH), 3.34 (m, 1H, η2-CH2dCHOC(O)CH3dCH2), 3.40, 3.93
(both m, 1H each, CH), 5.63 (m, 1H, η2-CH2dCHOC(O)CH3). 31P{1H}
NMR (CD2Cl2, 193 K): δ -47.73 (s). 13C{1H} NMR (CD2Cl2, 193
K): δ 4.60 (s, NCCH3), 14.66 (d, JCP ) 31.4, PCH3), 21.13 (s, η2-
CH2dCHOC(O)CH3), 24.65 (d, JCP ) 16.4, η2-CH2dCHOC(O)CH3),
25.57, 28.59, 36.00, 37.90 (all s, CH2), 64.16 (d, JCP ) 5.0, CH), 71.60
9
18082 J. AM. CHEM. SOC. VOL. 127, NO. 51, 2005